Short answer
STAAR SURGICAL CO (STAA) filed its Q3 2026 10-Q quarterly report on Aug 12, 2026 for the quarter ended Jul 3, 2026. Quarterly revenue was $94M (up 111.0% year over year) with net income of $8M.
Q3 2026 key financials · XBRL
- Revenue
- $94M
- +111.0% YoY · +0.0% QoQ
- Net income
- $8M
- +147.9% YoY · +54.8% QoQ
- Operating margin
- 10.8%
- Gross margin
- 74.5%
- EPS (diluted)
- $0.16
- +147.1% YoY · +60.0% QoQ
Source: XBRL data from the STAAR SURGICAL CO (STAA) Q3 2026 10-Q on SEC EDGAR. USD.
STAAR SURGICAL CO Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No risk factors provided; excerpt contains only Other Information, Exhibits, and Signatures
- CEO transition risk indicated by Warren Foust’s offer letter, effective August 4, 2026
- Leadership incentive risk indicated by performance stock option grants to Warren Foust and Deborah Andrews
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other STAAR SURGICAL CO quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.